SAB Biotherapeutics Inc (SABS) Price Prediction & ForecastSABSSAB Biotherapeutics Inc

Alphio's SABS stock price prediction model matches the current SAB Biotherapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.78 (+2.06%). The 1-week path is $3.76 (+1.67%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

SAB Biotherapeutics Inc is a good buy right now due to its current price of $3.79, which is significantly lower than the average analyst price target of $12.75, suggesting a potential upside of over 235%. Additionally, the company has a strong cash position of $217.6 million, providing operational runway through 2028 despite recent losses. However, the main risk is the net loss of $22.49 million reported in Q2 2026, which highlights ongoing financial challenges.

SAB Biotherapeutics Inc (SABS) last closed at $3.7, losing -0.27%. These facts feed the 1-day and 1-week SABS price prediction above.